Margaret Gatti
Family Medicine · Ocean View, DENPI 1851380364
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,382 and has fallen 81.9% since, to $251 in 2025.
Across 107 payments — averaging $33.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$478
- Novo Nordisk$405
- AstraZeneca$325
- Boehringer Ingelheim$319
- Mallinckrodt Hospital Products Inc.$269
- AbbVie$226
- plus $2K from 21 others
What the payments were for
- Food & beverage$3,541100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 20 | $478 |
| Novo Nordisk | 5 | $405 |
| AstraZeneca(2 entities) | 8 | $325 |
| Boehringer Ingelheim | 5 | $319 |
| Mallinckrodt Hospital Products Inc. | 12 | $269 |
| AbbVie | 12 | $226 |
| Lilly USA, LLC | 6 | $214 |
| Johnson & Johnson(2 entities) | 4 | $186 |
| Pfizer | 2 | $139 |
| Kyowa Kirin, Inc. | 1 | $126 |
| Idorsia Pharmaceuticals US Inc | 6 | $126 |
| Gilead | 1 | $125 |
| Biogen | 1 | $99 |
| Astellas Pharma US Inc | 4 | $75 |
| Novartis | 4 | $74 |
| GSK | 2 | $74 |
| UCB, Inc. | 3 | $66 |
| Fresenius Kabi USA, LLC | 2 | $36 |
| Radius Health, Inc. | 1 | $30 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| Sandoz | 1 | $21 |
| IBSA Pharma Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $20 |
| Exact Sciences | 1 | $19 |
| Genentech USA, Inc. | 1 | $15 |
| Organon | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,541 in reported general payments places this provider in the 85th percentile of 352 family medicine providers in Delaware.
Other family medicine in Ocean View
- Gregory PapaNew Castle$67K
- Sarah MullinsWilmington$36K
- Ashley PanichelliWilmington$27K
- Michelle PapaNewark$23K
- Maryann ConnorWilmington$21K
- Jill MackeyWilmington$20K
- Wayne TuckerBear$20K
- Ian MyersNewark$17K
- Glenn HamiltonWilmington$17K
- Dustin DavisGeorgetown$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.